Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

Oct. 1, 1997

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Warner-Lambert reports dihydropyrone HIV protease inhibitors

Sep. 30, 1997

Bayer evaluates novel heteroaryl oxazolidinones

Sep. 30, 1997

New class of antifungal agents developed at Glaxo Wellcome

Sep. 30, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

LY-333334: new bone anabolic agent from Lilly

Sep. 30, 1997

PathoGenesis presents new antimycobacterial agents

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

Clinical pharmacokinetics and bradycardic activity of S-16257

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...